BIOC logo

GlaxoSmithKline S.A.E Stock Price

CASE:BIOC Community·ج.م5.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

BIOC Share Price Performance

ج.م63.30
22.60 (55.53%)
ج.م63.30
22.60 (55.53%)
Price ج.م63.30

BIOC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with questionable track record.

2 Risks
0 Rewards

GlaxoSmithKline S.A.E Key Details

ج.م3.7b

Revenue

ج.م3.1b

Cost of Revenue

ج.م597.9m

Gross Profit

ج.م499.5m

Other Expenses

ج.م98.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.18
15.98%
2.63%
58.2%
View Full Analysis

About BIOC

Founded
1981
Employees
n/a
CEO
Hassan Fahmi
WebsiteView website
www.gsk.com/en-gb/contact-us/worldwide/egypt

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

Recent BIOC News & Updates

Recent updates

No updates

GlaxoSmithKline S.A.E Competitors